A blockbuster breast cancer niche has Roche and Sanofi in the lead

A blockbuster breast cancer niche has Roche and Sanofi in the lead

Πράσινο φως για 5 νέα φάρμακα στην ΕΕ.

Πράσινο φως για 5 νέα φάρμακα στην ΕΕ.

SABCS: Pfizer’s Ibrance backs up benefit in HER2-negative breast cancer with real-world data

SABCS: Pfizer's Ibrance backs up benefit in HER2-negative breast cancer with real-world data

10 Takeover Targets to Watch This Fall

10 Takeover Targets to Watch This Fall

5 questions ESMO cancer drug data might answer

5 questions ESMO cancer drug data might answer

Report: Projected Sales of 10 Top-Selling Drugs Through 2024

Κάντε like στη σελίδα μας στο facebook για να μαθαίνετε πρώτοι όλα τα νέα!!    Although some of the top-selling drugs in the world are facing patent cliffs between now and then, many of them are still projected to continue being big sellers between now and 2024. A recent report by Evaluate Pharma estimates prescription drug sales will … Συνεχίστε να διαβάζετε Report: Projected Sales of 10 Top-Selling Drugs Through 2024.